Postmenopausal hormone therapy, SERMs, and coronary heart disease in women

被引:0
作者
Nanette K. Wenger
D. Grady
机构
[1] Emory University School of Medicine,Departments of Epidemiology and of Medicine
[2] University of California,undefined
来源
Journal of Endocrinological Investigation | 1999年 / 22卷
关键词
Postmenopausal hormone therapy; coronary hearth disease; women; SERM;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:616 / 624
页数:8
相关论文
共 259 条
[1]  
Grady D(1992)Hormone therapy to prevent disease and prolong life in postmenopausal women Ann. Intern. Med 117 1016-1037
[2]  
Rubin SM(1995)Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women JAMA 273 199-208
[3]  
Petitti DB(1998)Hormone replacement therapy, heart disease, and other considerations Annu. Rev. Pub. Health 19 55-72
[4]  
Fox CS(1994)Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment J. Natl. Cancer Inst. 86 1534-1539
[5]  
Black D(1998)Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women JAMA 279 1444-1451
[6]  
Ettinger B(1991)Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence Prev. Med. 20 47-63
[7]  
Ernster VL(1987)Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study Circulation 75 1102-1109
[8]  
Cummings SR(1990)Estrogen replacement and coronary artery disease Arch. Intern. Med. 150 2557-2562
[9]  
Barrett-Connor E(1991)Decreased mortality in users of estrogen replacement therapy Arch. Intern. Med. 151 75-78
[10]  
Grady D(1996)Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions J. Am. Coll. Cardiol. 28 1111-1118